We would love to hear your thoughts about our site and services, please take our survey here.
Thank you for your email. A commercial update will be released by the end of January.
We appreciate all thoughts, remarks and comments from shareholders regarding Novacyt.
The company is strongly committed to market communication and Novacyt maintains regular contact with shareholders through publications such as the annual report and accounts, operational updates, regular press announcements carried out via a regulatory information and its website and social media profiles.
When we receive feedback directly from investors, it is carefully considered and appropriate action is taken if necessary. However, due to the volume of email received, it is no longer possible to respond directly to individual shareholders.
Sincere friendships,
??????????????
Good evening ,
The global context is exploding the demand for testing. this should benefit companies specializing in the field. I am surprised that Novacyt, a specialist in this field, does not communicate, and less and less over time. All listed companies communicate for their shareholders. Novacyt not! why be on the stock market then. I don't see the point anymore. what is the problem with this company?
Regards ,
Paul
Covid tests manufacturer in York close to settling £8.9m dispute with the department of health
Developer and manufacturer of rapid tests Abingdon Health swung to a loss, following a difficult and challenging year for the business as it looks set to resolve a dispute with the Government.
Hi Paul,
We are sure shareholders can appreciate David will want to spend time understanding the in's and out's of the business before talking to investors about it. David's employment history is in the public domain for all to see therefore David's time is best spent getting grips with the business for the moment, this should be of absolutely no concern to shareholders.
Kind regards,
Good Afternoon Mandy ,
It seems that the new CEO is of the same mold as GM, lack of communication and little interest for the shareholder.
He could have had the elegance to introduce himself and show his track record ….
I hope to be wrong of course
Regards